Diabetic Cardiomyopathy – Addressing a Growing Cardiometabolic Challenge

Diabetic cardiomyopathy is an emerging cardiovascular complication associated with diabetes and obesity, characterized by myocardial fibrosis, structural remodeling, and progressive cardiac dysfunction. Current research emphasizes early biomarkers and advanced imaging techniques, including cardiac MRI and speckle-tracking echocardiography, for detecting cardiac changes at an earlier stage. Emerging treatment strategies focus on metabolic modulation, anti-fibrotic therapies, gene-based approaches, and personalized interventions. Integrated care combining glycemic control, lifestyle modification, and continuous cardiovascular monitoring is essential for reducing heart failure risk and improving long-term outcomes in individuals with diabetes.

    Related Conference of Diabetic Cardiomyopathy – Addressing a Growing Cardiometabolic Challenge

    October 27-28, 2026

    3rd Global Summit on Geriatrics & Aging

    Rome, Italy
    December 03-04, 2026

    9th Annual Summit on Surgery and Transplantation

    Madrid, Spain
    January 28-29, 2027

    6th World Congress on Cardiac Surgery and Medical Devices

    Vancouver, Canada
    February 18-19, 2027

    10th World Congress on Surgeons

    Singapore City, Singapore
    March 15-16, 2027

    7th World Congress on Surgery

    London, UK
    March 22-23, 2027

    13th International Conference on Surgeons

    Singapore City, Singapore

    Diabetic Cardiomyopathy – Addressing a Growing Cardiometabolic Challenge Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in